Welcome to MutualFunds.com. Please help us personalize your experience.
Your personalized experience is almost ready.
Check your email and confirm your subscription to complete your personalized experience.
Thank you for your submission, we hope you enjoy your experience
Shauna O'Brien Mar 05, 2015
This is the first deal that the company has made since its terminated deal to acquire Ireland-based Shire.
Shares of ABBV dropped 2.5% on the news, while PCYC sales surged over 10%.
Despite the opportunity, shares of ABBV are down today, as many analysts see PCYC’s Imbruvica drug as unable to meet ambitious sales estimates.
|VTSMX||Vanguard Total Stock Mkt Idx||1.64%|
|VFINX||Vanguard 500 Index||1.10%|
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Subscribe to receive FREE updates, insigns, and more, straight to your inbox